Literature DB >> 22869132

Expression, purification, crystallization and preliminary X-ray analysis of 4-hydroxy-3-methyl-2-keto-pentanoate aldolase (asHPAL) from Arthrobacter simplex strain AKU 626.

Linjun Guo1, Masahiko Okai, Tomoko Mase, Fabiana Lica Imai, Takuya Miyakawa, Koji Nagata, Hiroyuki Yamanaka, Hidemi Fujii, Makoto Hibi, Jun Ogawa, Masaru Tanokura.   

Abstract

4-Hydroxy-3-methyl-2-keto-pentanoate aldolase (asHPAL), an enzyme used in the synthesis of (2S,3R,4S)-4-hydroxyisoleucine, was crystallized in the absence and the presence of 2-ketobutyrate as one of its substrates by the sitting-drop vapour-diffusion method using PEG 400 as a precipitant. Crystals of asHPAL grown without and with 2-ketobutyrate diffracted to 1.60 and 1.55 Å resolution and belonged to space group C2, with unit-cell parameters a = 116.8, b = 88.2, c = 85.3 Å, β = 122.3° and a = 116.2, b = 88.1, c = 85.0 Å, β = 122.3°, respectively.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22869132      PMCID: PMC3412783          DOI: 10.1107/S1744309112028278

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  11 in total

1.  4-Hydroxyisoleucine: effects of synthetic and natural analogues on insulin secretion.

Authors:  C Broca; M Manteghetti; R Gross; Y Baissac; M Jacob; P Petit; Y Sauvaire; G Ribes
Journal:  Eur J Pharmacol       Date:  2000-03-03       Impact factor: 4.432

2.  XDS.

Authors:  Wolfgang Kabsch
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

3.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

4.  4-Hydroxyisoleucine: a novel amino acid potentiator of insulin secretion.

Authors:  Y Sauvaire; P Petit; C Broca; M Manteghetti; Y Baissac; J Fernandez-Alvarez; R Gross; M Roye; A Leconte; R Gomis; G Ribes
Journal:  Diabetes       Date:  1998-02       Impact factor: 9.461

5.  Crystal structures of the metal-dependent 2-dehydro-3-deoxy-galactarate aldolase suggest a novel reaction mechanism.

Authors:  T Izard; N C Blackwell
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

6.  Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents.

Authors:  A M Jennings; R M Wilson; J D Ward
Journal:  Diabetes Care       Date:  1989-03       Impact factor: 19.112

7.  Branched chain aminotransferase isoenzymes. Purification and characterization of the rat brain isoenzyme.

Authors:  T R Hall; R Wallin; G D Reinhart; S M Hutson
Journal:  J Biol Chem       Date:  1993-02-15       Impact factor: 5.157

8.  On the mechanisms of the formation of L-alloisoleucine and the 2-hydroxy-3-methylvaleric acid stereoisomers from L-isoleucine in maple syrup urine disease patients and in normal humans.

Authors:  O A Mamer; M L Reimer
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

9.  A novel strategy for enzymatic synthesis of 4-hydroxyisoleucine: identification of an enzyme possessing HMKP (4-hydroxy-3-methyl-2-keto-pentanoate) aldolase activity.

Authors:  Sergey V Smirnov; Natalya N Samsonova; Anna E Novikova; Nikolay G Matrosov; Natalya Y Rushkevich; Tomohiro Kodera; Jun Ogawa; Hiroyuki Yamanaka; Sakayu Shimizu
Journal:  FEMS Microbiol Lett       Date:  2007-06-06       Impact factor: 2.742

Review 10.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

View more
  1 in total

1.  Crystals on the cover 2013.

Authors:  Howard Einspahr; Manfred S Weiss
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-12-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.